13 results
10-Q
2021 Q3
CGTX
Cognition Therapeutics Inc
17 Nov 21
Quarterly report
5:15pm
of the manufacturing process, specifically, raw materials manufacturing, drug substance manufacturing and drug product manufacturing. As a result … increase to existing manufacturing capacity in a timely manner, or at all. If our manufacturers or we are unable to purchase the raw materials necessary
424B4
CGTX
Cognition Therapeutics Inc
14 Nov 22
Prospectus supplement with pricing info
6:02am
operations of the manufacturing process, specifically, raw materials manufacturing, drug substance manufacturing and drug product manufacturing … to existing manufacturing capacity in a timely manner, or at all. If our manufacturers or we are unable to purchase the raw materials necessary
10-K
2021 FY
CGTX
Cognition Therapeutics Inc
30 Mar 22
Annual report
7:40am
product candidate involves several manufacturers that specialize in specific operations of the manufacturing process, specifically, raw materials manufacturing … manufacturers or we are unable to purchase the raw materials necessary for the manufacture of our product candidates on acceptable terms, at sufficient
DRS
dwn6t 3bg1r90cgz8
20 Oct 22
Draft registration statement
12:00am
S-1
1bsa0fyng1bujdo
19 Jul 21
IPO registration
7:02am
424B4
wzrd41wpx77
12 Oct 21
Prospectus supplement with pricing info
4:11pm
DRS
kzwezkvrdpw
7 May 21
Draft registration statement
12:00am
DRS/A
gao2xe1c
23 Jun 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next